PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells
- PMID: 15611321
- DOI: 10.1093/intimm/dxh194
PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells
Abstract
Since metastasis is the major cause of death for cancer patients, there is an urgent need to develop new therapies to control hematogenous dissemination of cancer cells. Previously we and others demonstrated a novel mechanism that allows tumors to escape from the host immune response by expressing PD-L1 which can negatively regulate immune response through the interaction with PD-1, an immunoinhibitory receptor belonging to the CD28 family. In this study, we report that hematogenous spread of poorly immunogenic B16 melanoma cells to the liver was inhibited in PD-1-deficient mice. After inoculation to spleen, PD-L1 was induced on tumor cells, which did not express PD-L1 in vitro. As compared with wild-type mice, intrasplenic injection of B16 cells into PD-1-deficient mice showed enhanced induction of effector T cells in spleen, prolonged T cell proliferation and cytokine production, and augmented homing of effector T cells to tumor sites in the liver, resulting in accumulation of effector T cells in the tumor sites. PD-1 blockade by genetic manipulation or antibody treatment inhibited not only hematogenous dissemination of B16 melanoma cells to the liver on the C57BL/6 background, but also dissemination of CT26 colon cancer cells to the lung on the BALB/c background. These results suggest that PD-1 blockade may be a powerful tool for treatment of hematogenous spread of various tumor cells.
Similar articles
-
Anti-programmed death-1 synergizes with granulocyte macrophage colony-stimulating factor--secreting tumor cell immunotherapy providing therapeutic benefit to mice with established tumors.Clin Cancer Res. 2009 Mar 1;15(5):1623-34. doi: 10.1158/1078-0432.CCR-08-1825. Epub 2009 Feb 10. Clin Cancer Res. 2009. PMID: 19208793
-
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade.Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12293-7. doi: 10.1073/pnas.192461099. Epub 2002 Sep 6. Proc Natl Acad Sci U S A. 2002. PMID: 12218188 Free PMC article.
-
PD-1 inhibits antiviral immunity at the effector phase in the liver.J Exp Med. 2003 Jul 7;198(1):39-50. doi: 10.1084/jem.20022235. J Exp Med. 2003. PMID: 12847136 Free PMC article.
-
Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.Clin Cancer Res. 2006 Nov 15;12(22):6808-16. doi: 10.1158/1078-0432.CCR-06-1558. Clin Cancer Res. 2006. PMID: 17121902
-
Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses.Transplantation. 2007 Mar 27;83(6):774-82. doi: 10.1097/01.tp.0000256293.90270.e8. Transplantation. 2007. PMID: 17414712
Cited by
-
Gut microbiome and nutrition-related predictors of response to immunotherapy in cancer: making sense of the puzzle.BJC Rep. 2023 Aug 2;1(1):5. doi: 10.1038/s44276-023-00008-8. BJC Rep. 2023. PMID: 39516566 Free PMC article. Review.
-
THP-1 Macrophages Limit Neutrophil Transendothelial Migration in a Model Infection.Cell Mol Bioeng. 2024 Jul 20;17(4):279-293. doi: 10.1007/s12195-024-00813-2. eCollection 2024 Aug. Cell Mol Bioeng. 2024. PMID: 39372553
-
Cell Identity and Spatial Distribution of PD-1/PD-L1 Blockade Responders.Adv Sci (Weinh). 2024 Nov;11(41):e2400702. doi: 10.1002/advs.202400702. Epub 2024 Sep 9. Adv Sci (Weinh). 2024. PMID: 39248327 Free PMC article. Review.
-
Resident memory T cells and cancer.Immunity. 2024 Aug 13;57(8):1734-1751. doi: 10.1016/j.immuni.2024.06.017. Immunity. 2024. PMID: 39142275 Review.
-
Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer.J Hematol Oncol. 2024 Jul 27;17(1):54. doi: 10.1186/s13045-024-01581-2. J Hematol Oncol. 2024. PMID: 39068460 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials